Personalized treatment for ovarian cancer

Links shared publicly online about this topic.

  • 718
    total visits

Personalized treatment for ovarian cancer

sciencedaily.com

Researchers have shown that point mutations -- misspellings in a single letter of genetic code -- that drive the onset and growth of cancer cells can be detected successfully in advanced ovarian cancer using a technique called OncoMap. The finding opens the way for personalized medicine.

View full resource at sciencedaily.com

Tags: Genetic, Hormone, Cancer, Ovarian Cancer, Personalized Medicine, Women's Health

  • Share

Most Recently Shared on November 18, 2010 at 2:22 pm By:

OvarianCancer_ Ovarian Cancer OW

Personalized treatment for ovarian cancer: Researchers have shown that point mutations -- misspellings in a sing... http://bit.ly/brua4r

1 year ago...

The path to personalized cancer treatment

labspaces.net — “In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published in Nature on Thursday 29 March 2012.View full resource at labspaces.net

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 1:30 pm By:

LabSpaces Brian Krueger Health News

The path to personalized cancer treatment - http://t.co/hn9MJh1j

2 weeks ago...

Testosterone may play a role in treatment of triple negative breast cancer

news-medical.net — “Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows the testosterone receptor may be a potential target to attack in treating triple negative breast cancer (TNBC).View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 4:01 pm By:

NewsMedical News-Medical.Net Health News

Testosterone may play a role in treatment of triple negative breast cancer: Could blocking a testosterone recept... http://t.co/WXw6ppYW

3 weeks ago...

Study Suggests Consuming Omega-3 Reduces Fatigue in Cancer Patients - Yahoo! News

news.yahoo.com — “From Yahoo! News: FIRST PERSON | A study published in the Journal of Clinical Oncology suggests that cancer patients who consume higher amounts of omega-3 polyunsaturated fatty acids (PUFAs) had less fatigue than those who did not. The beneficial results seem to be most pronounced in patients who consumed a small amount of omega-6 PUFAs compared to omega-3 intake. I'm undergoing treatment for breast cancer, and chemo and surgery have caused me to experience levels of fatigue I never thought possView full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 8:43 pm By:

HealthTrendster HealthTrendster Health Executive

Study Suggests Consuming Omega-3 Reduces Fatigue in Cancer Patients http://t.co/EHaBu1oN

3 weeks ago...

DNA marker predicts platinum drug response in breast, ovarian cancer

eurekalert.org — “Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies. The marker, found on chromosomes within the cancer cells, flags breast and ovarian cancer cells that can't repair the type of DNA damage caused by treatment with platinum drugs, including cisplatin and carboplatin.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 2:30 pm By:

EurekAlertAAAS EurekAlert! Health News

From @DanaFarber : #DNA marker predicts platinum drug response in breast, ovarian #cancer. http://t.co/42uuDOZc

3 weeks ago...

Famous Faces And Families Who Have Been Touched By Ovarian Cancer

huffingtonpost.com — “Oscar-winning actress Kathy Bates explained for the first time this week why she kept her 2004 ovarian cancer diagnosis a secret. She first revealed she had been diagnosed in 2009, but kept her experiences with treatment under wraps until divulging more details in an interview with Anderson Cooper.View full resource at huffingtonpost.com

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 2:13 pm By:

OvarianCancer_ Ovarian Cancer OW OW Health

Famous Faces And Families Who Have Been Touched By Ovarian Cancer: Oscar-winning actress Kathy Bates explained f... http://t.co/bft9qdFB

3 weeks ago...

Antioxidants Used as Anti-Aging Treatment May Also Kill Cancer Cells; Be Better Than Chemo

seniorjournal.com — “March 20, 2012 - Antioxidants have long been thought to have anti-aging properties, primarily by protecting a person's genetic material from damaging chemicals. A new study says they also kill cancer cells. Health news for senior citizens and baby boomers.View full resource at seniorjournal.com

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 5:59 pm By:

AntiAging_OW AntiAging Wisdom OW Health

Antioxidants Used as Anti-Aging Treatment May Also Kill Cancer Cells; Be Better Than Chemo: March 20, 2012 - Ant... http://t.co/kqZq923Q

4 weeks ago...

Arch Dermatol -- Abstract: Panniculitis Associated With Dermatomyositis and Recurrent Ovarian Cancer, March 19, 2012, Girouard et al. 0 (2012): archdermatol.2012.288v1

archderm.ama-assn.org — “Archives of Dermatology is a monthly professional medical journal published by the American Medical Association. Archives of Dermatology publishes original, peer-reviewed reports and discussions that address the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgeryView full resource at archderm.ama-assn.org

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 12:41 pm By:

OvarianCancer_ Ovarian Cancer OW OW Health

Panniculitis Associated With Dermatomyositis and Recurrent Ovarian Cancer [Observation]: Conclusions  Although p... http://t.co/Uc8Yiazv

4 weeks ago...

MabCure Announces Agreement with the City University of New York Center for Advanced Technology to Validate and Evaluate Its Monoclonal Antibodies as Ovarian Cancer Diagnostic Reagents | BioPortfolio.com

bioportfolio.com — “From BioPortfolio: MabCure Inc., (OTCBB:MBCI) a leading developer of antibody based technology for the diagnosis and treatment of Ovarian, Prostate, Colorectal and other cancers t...View full resource at bioportfolio.com

  • View Related
  • Share

Most Recently Shared on March 19, 2012 at 2:05 pm By:

BioPortfolio BioPortfolio Health News

BioPortfolio News MabCure Announces Agreement with the City University of New York Center for ... http://t.co/OqO7kOiK BioPortfolio News

4 weeks ago...

Treatment of Elderly Ovarian Cancer Patients in th... [Onkologie. 2012] - PubMed - NCBI

ncbi.nlm.nih.gov — “PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on March 17, 2012 at 6:29 am By:

OvarianCancer_ Ovarian Cancer OW OW Health

Treatment of Elderly Ovarian Cancer Patients in the Context of Controlled Clinical Trials: A Joint Analysis of t... http://t.co/cUzHRzzJ

4 weeks ago...

Ovarian Cancer

springer.com — “Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of ...View full resource at springer.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 6:27 pm By:

OvarianCancer_ Ovarian Cancer OW OW Health

Ovarian Cancer: Second Editionseries:Cancer Treatment and ResearchOvarian carcinoma continues to be responsible ... http://t.co/GanmC9SK

4 weeks ago...

Biology Researcher on the Verge of a Technological Breakthrough in Drug Creation Process | Biomarker Commons

biomarkercommons.org — “New technology being developed at Florida State University could significantly decrease the cost of drug discovery, potentially leading to increased access to high-quality health care and cancer patients receiving personalized chemotherapy treatments.View full resource at biomarkercommons.org

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 11:16 am By:

Symposier - Pasi Janne on new lung and colorectal cancer gene discovery | Dana-Farber Cancer Institute

symposier.com — “Uploaded and shared in Youtube by: DanaFarberCancerInst — The new frontier of cancer treatment, personalized medicine, involves identifying specific genetic abnormalities in cancerous cells and targeting them with drugs that are most likely to cause an effective response. Pasi Janne, MD, PhD, discusses the discovery that some types of non-small cell lung cancer and colorectal cancer share similar genetic abnormalities with cancers that are known to respond to targeted therapies, and explains howView full resource at symposier.com

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 4:17 pm By:

SympoPneumology Symposier Pneumology Support

Newly identified fusion genes in lung and colorectal cancer may guide treatment with 'targeted' drugs. http://t.co/THab6dZe

1 month ago...

Specialised cancer centers may improve survival rates for patients

news-medical.net — “Survival rates for cancer patients may be improved by treatment in specialised cancer centers, according to Cochrane researchers. In a review of recent studies, they found that women diagnosed with gynaecological cancer lived longer when treated in specialist compared to non-specialist units.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 4:43 am By:

NewsMedical News-Medical.Net Health News

Specialised cancer centers may improve survival rates for patients: Survival rates for cancer patients may be im... http://t.co/1vJdDrst

1 month ago...

Everist Genomics Develops Companion Diagnostics for Colorectal Cancer | IVD Technology

ivdtechnology.com — “Everist Genomics (EGI) announced the launch of the world's first comprehensive companion diagnostics and prognostics portfolio to improve early diagnosis, management and treatment of patients with colorectal cancer. The portfolio of four individual tests provides gene expression profiling and analysis of molecular markers to help physicians track tumor development and responsiveness to therapy, enabling personalized treatment across all stages of colorectal cancer.View full resource at ivdtechnology.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 4:50 pm By:

ivdtechnology IVD Technology Health Magazine

Everist Genomics Develops Companion Diagnostics for Colorectal Cancer http://t.co/A0O6VOPX

1 month ago...

IBM launches Clinical Genomics, cancer analytics platform | SmartPlanet

smartplanet.com — “The biomedical platform, dubbed Clinical Genomics, aims to deliver personalized treatments for a wide range of long-term health issues.View full resource at smartplanet.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 7:20 am By:

SmartPlanet SmartPlanet Health Site

IBM launches Clinical Genomics, cancer analytics platform http://t.co/8z8yEIJ3

1 month ago...

Advertisement